Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTissue DonorsTransplantation, AutologousWhole-Body IrradiationBone and BonesLiver TransplantationAnemia, AplasticTransplantation ConditioningHematopoietic Stem Cell TransplantationLeukemiaGraft SurvivalTransplantation ChimeraOocyte DonationBusulfanHistocompatibility TestingBone Marrow PurgingKidney TransplantationTissue and Organ ProcurementHistocompatibilityHematopoietic Stem CellsTransplantation, IsogeneicLiving DonorsCyclophosphamideBone Marrow DiseasesBlood DonorsHematopoiesisRecurrenceCombined Modality TherapyRadiation ChimeraMice, Inbred C57BLLeukemia, Myelogenous, Chronic, BCR-ABL PositiveGraft RejectionLeukemia, Myeloid, AcuteTreatment OutcomeBone Marrow ExaminationTime FactorsImmunosuppressive AgentsHematologic NeoplasmsRemission InductionPrecursor Cell Lymphoblastic Leukemia-LymphomaHepatic Veno-Occlusive DiseaseBone RemodelingTransplantation ImmunologyBone Marrow NeoplasmsGraft vs Host ReactionOrgan TransplantationLeukemia, MyeloidImmunosuppressionHeart TransplantationDirected Tissue DonationLeukocyte TransfusionLymphocyte DepletionStem Cell TransplantationAcute DiseaseLymphoma, Non-HodgkinRetrospective StudiesHLA AntigensT-LymphocytesSevere Combined ImmunodeficiencyChimeraSurvival AnalysisLung TransplantationColony-Forming Units AssayMyelodysplastic SyndromesCyclosporineActuarial AnalysisHematologic DiseasesBone DensityLymphocyte TransfusionNuclear FamilyAntineoplastic Combined Chemotherapy ProtocolsFollow-Up StudiesCarmustineGraft vs Tumor EffectCell DifferentiationPancytopeniaSurvival RateCytomegalovirus InfectionsLeukocyte CountGraft vs Leukemia EffectCytarabineSpleenGranulocyte Colony-Stimulating FactorBrain DeathMice, Inbred BALB CBone ResorptionMelphalanDisease-Free SurvivalFlow CytometryEtoposideLymphomaMultiple MyelomaCells, CulturedPancreas TransplantationFatal OutcomeBlood Transfusion